HDL – Immune Cell Crosstalk in Autoimmune Diseases and its Role in Accelerated Atherosclerosis

Abstract

Despite remarkable advances in lipid-lowering therapies, atherosclerotic cardiovascular disease (ASCVD) continues to be a major cause of morbidity and mortality worldwide, and chronic inflammation has been shown to contribute to residual cardiovascular risk.Autoimmune diseases are increasingly recognized as being associated with an increased risk of ASCVD that cannot be explained by traditional cardiovascular risk factors, such as dyslipidemia and hypertension.High-density lipoprotein (HDL) is an anti-atherogenic lipoprotein involved in reverse cholesterol transport. Recent studies have demonstrated that HDL possesses anti-inflammatory and immunomodulatory properties. In autoimmune diseases, both HDL dysfunction and immune dysregulation have been reported, including an impaired cholesterol efflux capacity (CEC), reduced paraoxonase-1 activity, alterations in HDL particle composition, and serum amyloid A enrichment. These findings suggest that crosstalk between HDL and immune cells may play an important role in atherosclerosis progression.Accordingly, this review summarizes the current evidence on HDL-immune cell interactions, discusses how HDL dysfunction contributes to accelerated atherosclerosis in autoimmune diseases, and highlights the therapeutic potential of targeting the HDL function to reduce residual cardiovascular risk or ASCVD risk.

Endocrine–Immune Crosstalk in Pediatric Autoimmune Diseases: A Systematic Review of the Role of Micronutrients, with Emphasis on Vitamin D
Atapattu Navoda, Sunil J. Wimalawansa
Nutrients24 Sep 2026Peer-reviewedCC BYFull textNutritionEurope PMC
Accelerated Systemic Atherosclerosis Following Immune-Related Adverse Events in a Patient with Primary Thoracic Melanoma: A Case of Sequential Coronary and Peripheral Revascularization
Tomoaki Nishikawa, Akinori Higaki, Saki Mori +3
Internal Medicine15 Oct 2026Peer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
Immune Landscape and Intercellular Crosstalk in the Cornea of an Autoimmune-Mediated Dry Eye Disease.
Luye An, Mario A Robledo, Seyyed Vahid Niknezhad +5
Investigative ophthalmology & visual science1 Oct 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
Microbiome-Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics.
Pranvi Sharma, Tanaka Nhokwara, Jaswinder Singh +2
Immunity, inflammation and disease1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
Multifaceted Physiological Roles of Lipoproteins and Understanding Atherosclerosis: Crosstalk Between Lipoproteins and Bioactive Lipids
Makoto Kurano
Journal of Atherosclerosis and Thrombosis28 Oct 2026Peer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaJ-STAGE

Cite

BibTeX RIS

BibTeX

@article{endo2026immune,
  title = {{HDL – Immune Cell Crosstalk in Autoimmune Diseases and its Role in Accelerated Atherosclerosis}},
  author = {Yasuhiro Endo and Kei Sasaki and Masatsune Ogura and Katsunori Ikewaki},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  month = sep,
  doi = {10.5551/jat.rv22061},
  url = {https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_RV22061/_article},
  note = {CC BY-NC-SA},
}

RIS

TY  - JOUR
TI  - HDL – Immune Cell Crosstalk in Autoimmune Diseases and its Role in Accelerated Atherosclerosis
AU  - Yasuhiro Endo
AU  - Kei Sasaki
AU  - Masatsune Ogura
AU  - Katsunori Ikewaki
PY  - 2026
DA  - 2026/09/19
JO  - Journal of Atherosclerosis and Thrombosis
DO  - 10.5551/jat.rv22061
UR  - https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_RV22061/_article
AB  - Despite remarkable advances in lipid-lowering therapies, atherosclerotic cardiovascular disease (ASCVD) continues to be a major cause of morbidity and mortality worldwide, and chronic inflammation has been shown to contribute to residual cardiovascular risk.Autoimmune diseases are increasingly recognized as being associated with an increased risk of ASCVD that cannot be explained by traditional cardiovascular risk factors, such as dyslipidemia and hypertension.High-density lipoprotein (HDL) is an anti-atherogenic lipoprotein involved in reverse cholesterol transport. Recent studies have demonstrated that HDL possesses anti-inflammatory and immunomodulatory properties. In autoimmune diseases, both HDL dysfunction and immune dysregulation have been reported, including an impaired cholesterol efflux capacity (CEC), reduced paraoxonase-1 activity, alterations in HDL particle composition, and serum amyloid A enrichment. These findings suggest that crosstalk between HDL and immune cells may play an important role in atherosclerosis progression.Accordingly, this review summarizes the current evidence on HDL-immune cell interactions, discusses how HDL dysfunction contributes to accelerated atherosclerosis in autoimmune diseases, and highlights the therapeutic potential of targeting the HDL function to reduce residual cardiovascular risk or ASCVD risk.
SN  - 1880-3873
SN  - 1340-3478
ER  -

Abstract

Related

Cite